Authors: Kuo, GH Prouty, C Murray, WV Pulito, V Jolliffe, L Cheung, P Varga, S Evangelisto, M Shaw, C

Citation: Gh. Kuo et al., Design, synthesis and biological evaluation of pyridine-phenylpiperazines:A novel series of potent and selective alpha(1a)-adrenergic receptor antagonist, BIO MED CH, 8(9), 2000, pp. 2263-2275

Authors: Li, XB McCoy, KA Murray, WV Jolliffe, L Pulito, V

Citation: Xb. Li et al., Novel heterocycles as selective alpha(1)-adrenergic receptor antagonists, BIOORG MED, 10(20), 2000, pp. 2375-2377

Authors: Li, XB Murray, WV Jolliffe, L Pulito, V

Citation: Xb. Li et al., Novel arylpiperazines as selective alpha(1)-adrenergic receptor antagonists, BIOORG MED, 10(10), 2000, pp. 1093-1096

Authors: Jolliffe, L

Citation: L. Jolliffe, Theme parks as flagship attractions in peripheral areas, ANN TOURISM, 27(1), 2000, pp. 250-252

Authors: Kuo, GH Prouty, C Murray, WV Pulito, V Jolliffe, L Cheung, P Varga, S Evangelisto, M Wang, J

Citation: Gh. Kuo et al., Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: A novel series of potent and selective alpha(1a)-adrenergicreceptor antagonists, J MED CHEM, 43(11), 2000, pp. 2183-2195

Authors: Richards, J Auger, J Peace, D Gale, D Michel, J Koons, A Haverty, T Zivin, R Jolliffe, L Bluestone, JA

Citation: J. Richards et al., Phase I evaluation of humanized OKT3: Toxicity and immunomodulatory effects of hOKT3 gamma(4), CANCER RES, 59(9), 1999, pp. 2096-2101